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Background: Hyperhomocysteinemia (HHcy) is an independent risk factor for liver diseases, such as fatty liver and
hepatic fibrosis. However, the mechanisms underlying this pro-oxidative effect of homocysteine (Hcy) in hepatocytes
remain largely unknown. Thus, we investigated the effect of Hcy on the gene expression of heme oxygenase-1 (HO-1),
the primary rate-limiting enzyme in heme catabolism and a key anti-oxidant detoxification enzyme in maintaining
cellular redox homeostasis.
Methods: In vivo, twenty male C57BL/6 mice at 8 weeks of age were randomly divided into two groups. One group
was fed a chow diet (chow group; n = 10), the other group of mice was fed a methionine-supplemented diet (Met group,
1 mg kg−1 day−1 L-methionine in drinking water; n = 10) for 4 weeks. In vitro, HepG2 cells were stimulated with different
doses of homocysteine (Hcy).
Results: Four weeks’ methionine supplementation caused a significant increase of plasma Hcy concentration and a
decrease of HO-1 expression in the liver of C57BL/6 mice than mice received chow diet. Besides, SOD enzyme activities
were impaired and the level of oxidative stress markers, such as malondialdehyde (MDA) were elevated in the liver from
mice supplemented with methionine compared with control mice. In cultured hepatocytes, Hcy treatment reduced
both the mRNA and protein levels of HO-1 dose-dependently. However, Hcy had no effect on the gene expression
of Nrf2, the major transcriptional regulator of HO-1. Instead, Hcy induced the expression of Bach1, a transcriptional
repressor of HO-1. In addition, Hcy stimulated the nuclear localization of Bach1 but prevented that of Nrf2. Furthermore,
we found that knockdown of Bach1 attenuated the suppression of the HO-1 expression by Hcy.
Conclusions: Collectively, our results demonstrated that Bach1 plays an important role in Hcy-triggered ROS generations
through inhibiting HO-1 expression, likely, resulting from the disturbed interplay between Bach1 and Nrf2.
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Homocysteine (Hcy) is a critical intermediate of methio-
nine metabolism and has profound importance in health
and diseases [1]. Indeed, the metabolism of Hcy mainly
takes place in liver and normal concentrations of total
Hcy in human plasma are 5–16 μmol/L [2]. The disrup-
ted metabolism of Hcy causes hyperhomocysteinemia
(HHcy). There are three ranges of HHcy: moderate
(16–30 μmol/L), intermediate (31–100 μmol/L), and
severe (>100 μmol/L) [3]. Epidemiological studies have
demonstrated that HHcy is an independent risk factor for* Correspondence: nanpingwang2003@yahoo.com
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unless otherwise stated.fatty liver diseases, cardiovascular disease, diabetes and so
on [3-7]. Clinical and experimental studies have shown
that pathophysiological effects of Hcy involved the ex-
cessive generation of reactive oxygen species (ROS) [8-10].
However, the molecular mechanisms underlying the effect
of Hcy on oxidative stress have not been explored.
Heme oxygenase-1 (HO-1), the primary rate-limiting
enzyme in heme catabolism, acts as a key anti-oxidant
detoxification enzyme in maintaining cellular redox ho-
meostasis [11]. HO-1 is involved in many pathophy-
siological changes of liver injuries including liver oxidative
stress, chronic inflammation and so on. It has been re-
ported that the induction of HO-1 as well as its reaction
products can protect the liver against damage caused by a
number of chemical compounds [12-16]. Otherwise,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and chronic inflammatory in liver, suggesting HO-1
induction as an important cellular endeavor for hepatopro-
tection [17,18]. The primary mechanism for up-regulation
of the HO-1 gene is by increasing transcription of this gene
[19,20]. This process is mediated by binding of nuclear
factor erythroid 2-related factor 2 (Nrf2), a basic leucine
zipper transcription factor, to antioxidant response elem-
ent (ARE) sequence [21]. In the presence of oxidative
stimuli, activated Nrf2 translocates into the nucleus, binds
to the heme-responsive elements (HeRE) in the 5′-UTR
of the HO-1 promoter, and commences transcription of
HO-1 [22,23]. However, the regulation of HO-1 in HHcy
has not been well studied. Therefore, we examined how
Hcy modulates the stress protein HO-1 in hepatocytes. In
the current study, we demonstrated that Nrf2 as well as
Bach1 are involved in the downregulation of HO-1 gene
expression by Hcy. The subcellular localisation of these




The animal experiments conform to the Guide for the
Care and Use of Laboratory Animals that was published
by the US National Institute of Health (NIH Publication
No. 8523, revised 1985). Male C57BL/6 mice at 8 weeks
of age were obtained from the Experimental Animal
Center of Xi’an Jiaotong University (Xi’an, China) and
fed with either chow diet (n = 10) or methionine-rich
diet (1 mg kg−1 day−1 L-methionine in drinking water;
n = 10) for 4 weeks. Each mouse was separately housed in
a temperature-controlled (24°C) facility with a 12 h light/
12 h dark cycle with free access to food and autoclaved
water. We weighed the mice every week and calculated
the consumption of water and food for each group. After
being anaesthetized by intraperitoneal injection of 3%
chloral hydrate, the blood of mice were collected from
the orbit. The study and all of the procedures were ap-
proved by the Xi’an Jiaotong University Animal Experiment
Committee.
Plasma Hcy determination
Plasma Hcy concentrations were measured as previously
described [24]. Briefly, the blood samples were collected
in EDTA-containing tubes, which were then immediately
centrifuged at 3,000 g for 10 min. The concentrations of
plasma total Hcy concentrations were quantified using
a fluorescence polarization immunoassay ELISA Kit
(Abbott IMx).
SOD enzyme activity unit determination
The livers were blotted dry and weighed and then
homogenized in 8 volumes of lysis buffer (pH7.4) at 4°Cfor 30 seconds using a polytron homogenizer. The hom-
ogenate was centrifuged at 12,000 × g for 15 min, and
then was used to detect the activity units of SOD en-
zyme by a commercial kit (Biovision).
Determination of Malondialdehyde (MDA)
The protein concentration of the supernatants of liver
homogenate was determined using the Pierce™ BCA
Protein assay kit (Thermo Fisher Scientific Inc., Rockford,
USA) according to the user manual. The MDA con-
centrations were detected with a kit according to the
manufacturer’s instructions (R&D Systems, Inc., USA)
and normalized to protein levels.
Cell culture
HepG2 cells (ATCC, Manassas, VA, USA) were cultured
with Dulbecco’s Modified Eagle’s Medium (DMEM) con-
taining 10% fetal bovine serum (FBS). Cells were seeded
into 6-well plates 24 h prior to treatments at approximately
80% confluence and exposed to different doses of Hcy
(Sigma-Aldrich, St. Louis, MO) for additional 24 h.
Quantitative reverse transcription PCR (qRT-PCR)
The total RNA of liver homogenate and cells were
obtained and qRT-PCR was conducted as previously
described [25]. Primers against Bach1 (forward primer,
5′-GGACACTCCTTGCCAAATGCAG-3′; reverse primer,
5′-TGACCTGGTTCTGGGCTCTCAC-3′); Nrf2 (forward
primer, 5′-AGC ACACCCAGTCAGAAACCAG-3′; re-
verse primer, 5′-TCTACAAACGGGAATGTCG-3′); HO-1
(forward primer, 5′-CGCTGGCAGGAGGTCAT-3′; re-
verse primer, 5′-CATCGGAGAAGCGGAGC-3′) and
GAPDH ((forward primer, 5′- ACCACAGTCCATGCCA
TCAC-3′; reverse primer, 5′-TCCACCACCCTGTTGCT
GTA-3′) were designed using the sequence information of
the NCBI database. The PCR conditions were as follows:
initial denaturation: 95°C, 5 min; 40 cycles of denaturation
(95°C, 30 s), annealing (58°C, 30 s), and elongation (72°C,
60 s). The fluorescent signals were collected during the
extension phase, Ct values of the sample were calculated,
and the mRNA levels were analyzed by 2-△△Ct method.
Western blotting
Proteins from liver homogenate were extracted with
ice-cold lysis buffer (Roche, Mannheim, Germany). Add-
itionally, the nuclear proteins were extracted by the Pierce
NE-PER kit (Pierce, Rockford, IL, USA) according to the
manufacturer’s instruction. All steps were carried out on
ice. Proteins concentrations were determined by the BCA
assay (Pierce). Protein (25 μg) from each sample was sepa-
rated by 10–12% SDS-PAGE and electrotransferred to
Polyvinylidene Fluoride (PVDF) membranes. The mem-
branes were blocked with 5% BSA for 1 h at room
temperature and incubated overnight at 4°C using the
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Technology Inc. MA, USA) of HO-1 (#5853), Bach1
(#4578), Nrf2 (#12721), Histone and mouse antibody of
β-actin, followed by 1:4000 dilution of goat anti-rabbit
or goat anti-mouse horseradish peroxidase-labeled anti-
bodies (Cell Signaling Technology Inc. MA, USA). The
bands were visualized using the ECL system, and the band
density was determined by Image J software (NIH, USA).
Measurement of reactive oxygen species
The intracellular ROS level of cells was detected by fluores-
cence microscope and flow cytometry using the fluorescent
probe 2′,7′-Dichlorofluorescin diacetate (DCFH-DA), which
is a cell-permeable non-fluorescent probe and turns to
highly fluorescent 2′,7′-Dichlorofluorescin (DCF) upon
oxidation. The cells were quiesced for 24 h and treated
with different doses of Hcy for additional 24 h or H2O2
(100 μM) for 30 min as a positive control. Then, the
cells were washed with PBS, and incubated with 10 μM
DCFH-DA at 37°C for 30 min in dark. After incubation,
the cells were washed with PBS and observed under
fluorescent microscopy directly or adjusted to a con-
centration of 1 × 106/mL after trypsinization and ana-
lyzed by FACScan (BD FACSAriaTM III, United States)
within 30 min. 10,000 cells were counted in each deter-
mination and the specific fluorescence signals were col-
lected with a 488-nm band pass filter.
Luciferase reporter assay
The HO-1 promoter reporter (pGL3-HO-1) was con-
structed. The fragment spanning from −3000 base pairs
upstream of the transcription start of the human HO-1
gene was subcloned into pGL3-basic plasmid containing
the ARE sequence and the firefly luciferase reporter gene
(Promega Corporation, Madison, USA). The reporter plas-
mid and β-gal were transfected into HepG2 cells using the
Lipofectamine 2000 reagents from Invitrogen according to
the manufacturer’s instructions. These cells were subse-
quently treated with different dose of Hcy (0, 100, 500,
1000 μM) for 24 h. Cell lysates were harvested to measure
the luciferase activities using the Dual-Luciferase® Reporter
Assay System (Promega). The luciferase activities were then
normalized to β-galactosidase activity.
Gene silencing
To knock down Bach1 expression, cells were transfected
with 100 pmol Bach1 siRNA, a commercially available
small interfering RNAs (siRNAs) duplex components
against this molecule (sc-37064; Santa Cruz, CA, USA)
or a negative control siRNA (sc-37007; Santa Cruz, CA,
USA), a RNA duplex with no known sequence hom-
ology, in a 12-well format using Lipofectamine 2000
(Invitrogen, Carlsbad, CA) according to the manufac-
turer’s instructions.Statistical analysis
All of the experiments were repeated at least three
times. Data are expressed as means ± SEM. The signifi-
cance of differences between 2 or more than 2 groups
was determined by Tamhane’s test and one-way ANOVA,
respectively, using SPSS 16.0 software (SPSS, Chicago, IL).
A value of P < 0.05 was considered to be statistically
significant.
Results
Hcy accumulation increased oxidative stress and
down-regulated HO-1 expression in mouse livers
To determine the effect of Hcy on HO-1 expression,
mice were supplemented with L-methionine in drinking
water (Met group). After 4 weeks of treatment, the
plasma Hcy concentrations significantly raised compared
to those in chow diet-fed mice (chow group) (Figure 1A).
It is well established that oxidative stress is implicated in
Hcy-caused liver injury. Relative analysis demonstrated
that SOD enzyme activity was decreased significantly to
45.9% in Met groups compared with the Chow group
mice (Figure 1B). Furthermore, the mice from Met
group had higher levels of MDA in livers than chow
group (Figure 1C). Next, we identify the effect of ele-
vated Hcy on the expression of HO-1, a key anti-oxidant
detoxification enzyme in maintaining cellular redox
homeostasis. The mRNA levels of HO-1 were remark-
ably reduced in Met group than chow group (Figure 1D).
Then, liver homogenate supernatants were then assayed
by Western blotting. Consistently, the mice from Met
group had an obvious decrease in HO-1 expression com-
pared with chow group (Figure 1E). We also detected the
effects of increased level of Hcy on the expression of
Bach1 and Nrf2, which are two main regulator of HO-1.
As shown in Figure 1F, Met supplementation induced
Bach1 protein level whereas the expression of Nrf2 was
comparable between two groups.
Hcy dose-dependently induced intracellular ROS production
in hepatocytes
Next, we performed in vitro culture of HepG2 cells with
Hcy. The concentrations in this study did not affect cell
viability (Additional file 1: Figure S1). The effect of Hcy
on intracellular ROS levels is shown in Figure 2. Cells
were treated with different doses of Hcy for 24 h and the
ROS levels were determined by flow cytometry or fluores-
cent microscope after incubation of the fluorescent probe
DCFH-DA. Hcy increased the intracellular ROS levels in a
dose-dependent manner (Figure 2A and 2B). As a positive
control, the treatment with 100 μM H2O2 for 30 min
significantly triggered ROS generation of HepG2 cells.
Similar results were obtained by fluorescent microscope.
Hcy dose-dependently enhanced the intensity of fluores-
cence signal of DCF (Figure 2C).
Figure 1 Hcy accumulation resulted in oxidative stress and HO-1 downregulation. (A) Hcy concentrations of plasma were determined by
an ELISA assay and indicated for each group of C57BL/6 J mice (n = 7 for each group). The livers were homogenized and the total protein
concentrations were assessed to determine the enzyme activity units of SOD by WST-1 method (B) and the MDA concentrations using an ELISA
assay (C). (D) The total RNA of livers were extracted and subjected to qRT-PCR for the assessment of HO-1 mRNA level. The bar graph shows
mRNA levels of HO-1 after normalization to GAPDH. Protein levels of HO-1, Bach1 and Nrf2 were analyzed using Western blotting (E and F).
β-actin was used as an internal control to ensure equal loading in all lanes of the gel. Representative results of 3 independent experiments are
shown. Data are presented as means ± SEM from 3 three independent experiments. *P < 0.05 vs. mice fed with chow diet.
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To determine the effect of Hcy on HO-1 expression in
HepG2 cells, qRT-PCR and Western blotting were perfor-
med to detect the mRNA and protein levels of HO-1,
respectively. As shown in Figure 3A, Hcy dose-dependently
decreased the HO-1 mRNA levels after 24 h exposure. The
statistical analysis showed that HO-1 expression levels
significantly differ from each other (P < 0.05). In order
to examine whether the effect of Hcy on HO-1 mRNA
expression is on a transcriptional level, we cloned a
luciferase-reporter driven by the 3 kb HO-1 promoter
fragment of the human HO-1 gene. The results of lucif-
erase assays showed that Hcy inactivated the HO-1 pro-
moter dose-dependently (Figure 3B). Next, we detected
the expression of HO-1 protein by western blotting
assays. Compared with untreated cells, HO-1 protein
expression declined to 98.1%, 54.3% and 23.7% in cells
treated with Hcy at the concentrations of 100, 500 and
1000 μM, respectively, and the differences were statis-
tically significant from each other (Figure 3C). We also
determined the mRNA level of Nqo1 and GSTA1, other
two target genes of Nrf2, and found that Hcy reduced the
expression of Nqo1 dose-dependently whereas the expres-
sion of GSTA1 was only decreased in higher doses of Hcy
(Additional file 1: Figure S2).Hcy had opposite effects on the nuclear localization of
Bach1 and Nrf2
Since Bach1 can down-regulate HO-1 transcription
through competing with Nrf2 for the binding of antioxi-
dant response element (ARE), the levels of nuclear and
cytosolic Bach1 and Nrf2 were examined by Western blot-
ting. The proteins in cytoplasm were shown in Figure 4A,
the Nrf2 protein elevated gradually following Hcy treat-
ment at concentrations of 100, 500 and 1000 μM while
the fractions of Bach1 were decreased remarkably com-
pared to those of control cells. The statistical analysis
showed significant differences from each other (Figure 4C,
P < 0.05). In contrast with the localization of the two pro-
teins in cytoplasm, nuclear Bach1 accumulated and nu-
clear Nrf2 reduced dramatically after Hcy exposure at the
concentrations above (Figure 4B and D).
Hcy induced the expression of Bach1 but not Nrf2 in
HepG2 cells
We next evaluate the effect of Hcy on Nrf2 gene expres-
sion since Nrf2 is involved in cellular protection against
oxidative stress through antioxidant response element
(ARE)-directed induction of several phase 2 detoxifying
and antioxidant enzymes, including HO-1 [26]. Interest-
ingly, Hcy had no significant effect on Nrf2 mRNA levels.
Figure 2 Effect of Hcy on intracellular ROS production. Cells were cultured without serum for 24 h and then treated with Hcy (100, 500, 1000 μM)
for another 24 h. The intracellular ROS level of cells was detected by fluorescence microscope and flow cytometry using the fluorescent probe DCFH-DA
(10 μM, 30 min). H2O2 (100 μM, 30 min) treatment is a positive control. (A) The ROS production was detected by DCFH-DA staining. The images are
representative of typical staining (400×; scale bar: 20 μM). Digital scans of DCHF-DA-stained cells were quantified using Image J software (B). Data are
shown as means ± SEM of three independent experiments. (C) The ROS levels were detected by flow cytometry analysis. Data are represented as
percentages of the control group from six independent experiments (*P < 0.05 vs. control).
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factor Bach1, which was suggested to represses the tran-
scription of HO-1, increased in a concentration-related
manner after Hcy treatment (Figure 5).
Bach1 siRNA reversed the suppression of HO-1 expression
by Hcy
To determine the effect of Bach1 on the regulation of
HO-1 expression in Hcy-treated HepG2 cells, we silenced
human Bach1 gene expression by Bach1 siRNA. After the
transfection of 100 pmol Bach1 siRNA for 72 h, the Bach1
protein level was markedly reduced to 16% compared to
those of control siRNA-treated cells (Figure 6A). The
levels of HO-1 mRNA were significantly increased
(37.1-fold) after exposure to Bach1 siRNA without Hcy
treatment. Compared to control siRNA-treated cells,
Bach1 siRNA treatment significantly reversed the sup-
pression of HO-1 gene expression by Hcy (Figure 6B).
However, Hcy failed to attenuate the expression of HO-1
significantly in Bach1 siRNA-treated cells even with aslight decrease (P = 0.12, 0.09 and 0.07 for Hcy at the
concentrations of 100, 500 and 1000 μM, respectively,
when compared with Bach1 siRNA-treated cells only).
Discussion
Hyperhomocysteinemia (HHcy) is an independent risk
factor for liver diseases, such as fatty liver and hepatic
fibrosis [5]. The pathophysiological changes of HHcy-
induced liver injuries include chronic inflammation, fibro-
sis, cirrhosis, and so on. In the present study, we provided
novel result that Hcy decreased the expression of HO-1, a
key anti-oxidant detoxification enzyme, via deregulated
interplay between Nrf2 and Bach1, resulting oxidative
stress in hepatocytes. This effect of Hcy on HO-1 is highly
dose-dependent and may represent another mechanism
contributing to the pro-oxidative effects of Hcy.
Nutritional factors such as high methionine-diet are
associated with increased serum homocysteine levels. Ex-
tensive studies have shown that a high methionine-diet
had awful effects on liver pathophysiology, for instance,
Figure 3 Hcy dose-dependently down-regulates HO-1 gene expression in HepG2 cells. HepG2 cells were treated with the indicated
concentrations of Hcy for 24 h. (A) Total RNA was extracted and subjected to qRT-PCR for the assessment of HO-1 mRNA level. The bar graph
shows mRNA levels of HO-1 after normalization to GAPDH. Data are presented as means ± SEM from 3 three independent experiments. *P < 0.05
vs. control. (B) HepG2 cells were transfected with the HO-1-pGL3 plasmid and then exposed to Hcy for 24 h. The data are expressed as fold
change of the luciferase activities normalized toβ-gal activity compared to control. *P < 0.05 vs. control; n = 4. (C) Protein levels of HO-1 were
analyzed using Western blotting. Representative results of three independent experiments are shown. β-actin was used as an internal control to
ensure equal loading in all lanes of the gel.
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and fibrosis [27,28]. Our observations are in line with
previous studies reporting that methionine supplemen-
tation increased plasma Hcy levels, triggered oxidative
stress of livers and impaired the anti-oxidative enzyme
activity. Furthermore, methionine treatment attenuated
the expression of HO-1 in the liver. Therefore, we next
performed in vitro culture of hepatocytes to Hcy and
found that Hcy treatment dose-dependently down-
regulates HO-1 expression. These results suggested that
Hcy accumulation has a promoting effect on oxidative
stress, which might be partially contributed by the de-
crease of anti-oxidative enzyme HO-1. However, whether
Hcy affect the HO-1 enzymatic activity remains to be
characterized and this limitation is warranted to be exam-
ined in future study.
Nrf2 is the main transcriptional activator of the HO-1
gene in response to various forms of stimulation such
as oxidative stress [29]. Activation of the Nrf2/HO-1
pathway can protect cells from oxidative stress-induced
damage [30]. Antioxidants are strong activators of Nrf2
because after metabolism they produce a small amount
of oxidative stress that signals Nrf2 activation [31-33].Inversely, chemicals with oxidant stimulation are able
to repress Nrf2/HO-1 pathway [34-36]. In the present
study, we found that Hcy which triggered ROS gener-
ation significantly inhibited HO-1 mRNA and protein
levels in HepG2 cells. As for the result that Nrf2 mRNA
levels did not change obviously after Hcy treatment, it is
possible that a decreased binding of Nrf2 to ARE sequence
is a potential mechanism as well. Firstly, the decreased
nuclear translocation of Nrf2 would lead to a reduced
binding to its cognate sequences in the target gene HO-1.
Secondly, the transfection and ChIP assays indeed confir-
med that Bach1 and Nrf2 competed with each other on
the ARE sequence in HepG2 cells [37].
Like Nrf2, Bach1 is also a member of the basic leucine
zipper family of proteins [38]. It was previously reported
that Bach1 plays a critical role in heme-dependent down-
regulation of the human HO-1 gene [39,40]. Sun et al. have
showed that HO-1 is constitutively expressed at higher
levels in many tissues of Bach1-deficient mice, suggesting
that Bach-1 acts as a negative regulator of transcription of
the mouse HO-1 gene [41]. Here, our results demonstrated
that Hcy induced Bach1 expression at the transcriptional
level. Further RNA interference experiments allowed us to
Figure 4 Hcy induced nuclear import of Bach1 and the export of Nrf2. The cytosolic and nuclear proteins were extracted separately after
Hcy treatment and subjected to Western blotting assay. Representative images of three independent experiments were shown. The cytosolic
(A) and nuclear (B) proteins were present to illustrate the changes of subcellular localization of Nrf2 and Bach1. The values of density of proteins
were justified with β-actin (C) and Histone (D), accordingly. The relative density ratios of untreated cells were set at a value of 1.0. The values are
means ± SEM from three independent experiments. *P < 0.05 vs. control.
Luo et al. Nutrition & Metabolism 2014, 11:55 Page 7 of 10
http://www.nutritionandmetabolism.com/content/11/1/55confirm the core role of Bach1 in the suppression of HO-1
to Hcy. On the other hand, Bach1 can regulate HO-1 gene
expression by competing with Nrf2 [42,43]. Under oxi-
dative stress, Nrf2 is released from Keap1 and translo-
cated into the nucleus. In the nucleus, Bach1 can form
heterodimers with the Maf-related protein family [44],Figure 5 Hcy dose-dependently increases Bach1 but not Nrf2
mRNA levels. Cells were treated with Hcy at indicated concentrations
for 24 h. The mRNA levels of Bach1 and Nrf2 were quantified by
qRT-PCR assay. Relative mRNA amounts of Bach1 and Nrf2 were
normalized to GAPDH. Data shown are as means ± SEM of three
independent experiments. *P < 0.05 vs. control.and then leads to switching off Nrf2 and suppression of
cytoprotective gene expression to basal levels through
competition with Nrf2 for binding to ARE [37]. Hence,
the nuclear import of Bach1 is supposed to allow for un-
hindered nuclear export of Nrf2. As expected, we found
Hcy treatment caused an alteration of nuclear localiza-
tions of Bach1 and Nrf2. Consequently, this modification
process of the two transcription factors was associated
with a significant decrease in the expression of the down-
stream cytoprotective phase 2 genes HO-1. These results
demonstrated that the increase of Bach1 gene expres-
sion and its nuclear translocation potentiated the down-
regulation of the HO-1 by Hcy.
A previous study has suggested that incubation of Hcy
for very short time (45 min) induced the expression of
HO-1 in HepG2 cells [45]. It seems that the oxidative
stress provoked by Hcy stimulated the immediate cellu-
lar response in HepG2 cells by activating the Nrf2-ARE
pathway. However, some certain degree of maladaptation
will occur when cells were exposed to higher levels of
Hcy at longer duration. It has been reported that high
levels of Hcy (500 μM) were able to abolish hypoxia-
mediated HO-1 expression in a concentration-dependent
manner [46]. Actually, the mechanism of signal transduc-
tion from antioxidant to Nrf2 is complex and involves
basal, pre-induction, induction and post-induction phases
[47]. Cellular exposure to oxidants usually firstly triggers
the pre-induction response in which negative regulators of
Figure 6 The effect of Bach1 on the regulation of HO-1 expression in Hcy-treated HepG2 cells. Cells were treated with 100 pmol
Bach1siRNA or control siRNA for 72 h before Hcy treatment (0, 100, 500, 1000 μM for 24 h). (A) Protein level of Bach1 was analyzed using Western
blotting. β-actin was used as a internal control. Representative image of three independent experiments was shown. (B) HO-1 mRNA levels were
detected by qRT-PCR. Each data point represents means ± SEM from three independent experiments. Values for cells treated with control siRNA-only
were set equal to 1. The two curves are significantly different from one another using nonlinear regression analysis (P < 0.001) and the data points are
significantly different from one another. *P < 0.05 vs. cells treated with control siRNA-only.
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itself is activated and increase HO-1 transcription to
defense oxidative stress. However, it is worth noting that
this protective benefit is limited since the induction
phase Nrf2 is followed by the post-induction phase,
which switches off Nrf2 activation [48].
In summary, our results showed that Hcy markedly re-
duces HO-1 mRNA and protein levels in hepatocytes. ThisFigure 7 Schematic model of effect of Hcy on HO-1 expression via re
Bach1, a repressor of HO-1 gene expression, is increased. Bach1 also comp
reduces HO-1 transcription.down-regulation effect was associated with up-regulation
of Bach1 mRNA levels. In addition, Hcy promoted the al-
teration of nuclear localization of Bach1and Nrf2 (Figure 7).
The results of our study confirmed that the subcelluar
localizations of Nrf2 and Bach1 caused by the excessive
oxidative stress in Hcy-treated hepatocytes could account
for the down regulation of HO-1 expression, which may
be responsive for the HHcy-induced liver injury.gulation of Bach1 and Nrf2. With high levels of Hcy, expression of
etes with Nrf2 to bind antioxidant response element (ARE), then
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Additional file 1: Figure S1. The effect of different dose of Hcy on cell
viability. After the treatment of different doses of Hcy for 24 h, cells were
incubated for additional 4 h in the presence of a MTT labelling mixture.
The absorbance of the samples was measured at 550 nm with using a
microliter plate (ELISA) reader. The results were presented as fold change
of the absorbance against the blank compared to control. Figure S2.
Hcy down-regulates gene expressions of Nqo1 and GSTA1. HepG2 cells
were treated with the indicated concentrations of Hcy for 24 h. Total
RNA was extracted and subjected to qRT-PCR for the assessment of Nqo1
(A) and GSTA1 (B) mRNA levels. The bar graph shows mRNA levels of
the two genes after normalization to GAPDH. Data are presented as
means ± SEM from 3 three independent experiments. *P < 0.05 vs. control.
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